nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CHRM3—Carbachol—glaucoma	0.097	0.124	CbGbCtD
Tolterodine—CHRM3—Pilocarpine—glaucoma	0.0902	0.115	CbGbCtD
Tolterodine—CHRM1—Carbachol—glaucoma	0.0844	0.108	CbGbCtD
Tolterodine—CHRM1—Pilocarpine—glaucoma	0.0784	0.1	CbGbCtD
Tolterodine—CHRM2—Carbachol—glaucoma	0.0778	0.0994	CbGbCtD
Tolterodine—CHRM2—Pilocarpine—glaucoma	0.0723	0.0924	CbGbCtD
Tolterodine—CYP2D6—Carteolol—glaucoma	0.0348	0.0445	CbGbCtD
Tolterodine—CYP2D6—Betaxolol—glaucoma	0.0235	0.03	CbGbCtD
Tolterodine—CYP2C19—Methazolamide—glaucoma	0.0234	0.0299	CbGbCtD
Tolterodine—CYP2C9—Diclofenamide—glaucoma	0.0226	0.0289	CbGbCtD
Tolterodine—CYP2C9—Dorzolamide—glaucoma	0.0219	0.0279	CbGbCtD
Tolterodine—CYP2C19—Timolol—glaucoma	0.0199	0.0255	CbGbCtD
Tolterodine—CYP2C9—Methazolamide—glaucoma	0.0195	0.0249	CbGbCtD
Tolterodine—CYP2D6—Methazolamide—glaucoma	0.0178	0.0228	CbGbCtD
Tolterodine—CYP3A4—Pilocarpine—glaucoma	0.0168	0.0214	CbGbCtD
Tolterodine—CYP2D6—Timolol—glaucoma	0.0151	0.0193	CbGbCtD
Tolterodine—CYP3A4—Brinzolamide—glaucoma	0.0132	0.0168	CbGbCtD
Tolterodine—CYP2D6—Clonidine—glaucoma	0.0129	0.0165	CbGbCtD
Tolterodine—CYP3A4—Dorzolamide—glaucoma	0.0127	0.0162	CbGbCtD
Tolterodine—CYP3A4—Methazolamide—glaucoma	0.0113	0.0145	CbGbCtD
Tolterodine—CYP3A4—Acetazolamide—glaucoma	0.00905	0.0116	CbGbCtD
Tolterodine—CYP3A4—Clonidine—glaucoma	0.00819	0.0105	CbGbCtD
Tolterodine—Chest pain—Apraclonidine—glaucoma	0.00057	0.00289	CcSEcCtD
Tolterodine—Asthenia—Carteolol—glaucoma	0.000559	0.00284	CcSEcCtD
Tolterodine—Dry mouth—Apraclonidine—glaucoma	0.000557	0.00282	CcSEcCtD
Tolterodine—Dizziness—Metipranolol—glaucoma	0.000557	0.00282	CcSEcCtD
Tolterodine—Dysuria—Clonidine—glaucoma	0.000556	0.00282	CcSEcCtD
Tolterodine—Flushing—Pilocarpine—glaucoma	0.000553	0.0028	CcSEcCtD
Tolterodine—Chest pain—Bimatoprost—glaucoma	0.000552	0.0028	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Clonidine—glaucoma	0.000552	0.0028	CcSEcCtD
Tolterodine—Anxiety—Bimatoprost—glaucoma	0.000551	0.00279	CcSEcCtD
Tolterodine—Asthenia—Diclofenamide—glaucoma	0.00055	0.00279	CcSEcCtD
Tolterodine—Disorientation—Timolol—glaucoma	0.000547	0.00277	CcSEcCtD
Tolterodine—Oedema—Apraclonidine—glaucoma	0.000546	0.00277	CcSEcCtD
Tolterodine—Hypersensitivity—Levobunolol—glaucoma	0.000543	0.00275	CcSEcCtD
Tolterodine—Infection—Apraclonidine—glaucoma	0.000543	0.00275	CcSEcCtD
Tolterodine—Weight increased—Clonidine—glaucoma	0.000541	0.00274	CcSEcCtD
Tolterodine—Dry mouth—Bimatoprost—glaucoma	0.00054	0.00274	CcSEcCtD
Tolterodine—Flatulence—Brinzolamide—glaucoma	0.000532	0.00269	CcSEcCtD
Tolterodine—Asthenia—Levobunolol—glaucoma	0.000529	0.00268	CcSEcCtD
Tolterodine—Headache—Metipranolol—glaucoma	0.000527	0.00267	CcSEcCtD
Tolterodine—Infection—Bimatoprost—glaucoma	0.000526	0.00267	CcSEcCtD
Tolterodine—Dizziness—Carteolol—glaucoma	0.000516	0.00261	CcSEcCtD
Tolterodine—Urinary tract infection—Clonidine—glaucoma	0.000515	0.00261	CcSEcCtD
Tolterodine—Diarrhoea—Carbachol—glaucoma	0.000512	0.0026	CcSEcCtD
Tolterodine—Flatulence—Pilocarpine—glaucoma	0.000511	0.00259	CcSEcCtD
Tolterodine—Palpitations—Brimonidine—glaucoma	0.000508	0.00257	CcSEcCtD
Tolterodine—Dizziness—Diclofenamide—glaucoma	0.000507	0.00257	CcSEcCtD
Tolterodine—Asthenia—Methazolamide—glaucoma	0.000506	0.00257	CcSEcCtD
Tolterodine—Diarrhoea—Levobunolol—glaucoma	0.000504	0.00256	CcSEcCtD
Tolterodine—Angioedema—Dorzolamide—glaucoma	0.000501	0.00254	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.000498	0.00252	CcSEcCtD
Tolterodine—Bronchitis—Betaxolol—glaucoma	0.000498	0.00252	CcSEcCtD
Tolterodine—Dizziness—Carbachol—glaucoma	0.000495	0.00251	CcSEcCtD
Tolterodine—Vertigo—Dorzolamide—glaucoma	0.000493	0.0025	CcSEcCtD
Tolterodine—Confusional state—Acetazolamide—glaucoma	0.000493	0.0025	CcSEcCtD
Tolterodine—Vertigo—Travoprost—glaucoma	0.000491	0.00249	CcSEcCtD
Tolterodine—Chest pain—Brimonidine—glaucoma	0.000489	0.00248	CcSEcCtD
Tolterodine—Arthralgia—Brimonidine—glaucoma	0.000489	0.00248	CcSEcCtD
Tolterodine—Anaphylactic shock—Acetazolamide—glaucoma	0.000489	0.00248	CcSEcCtD
Tolterodine—Headache—Carteolol—glaucoma	0.000488	0.00248	CcSEcCtD
Tolterodine—Anxiety—Brimonidine—glaucoma	0.000487	0.00247	CcSEcCtD
Tolterodine—Dizziness—Levobunolol—glaucoma	0.000487	0.00247	CcSEcCtD
Tolterodine—Somnolence—Apraclonidine—glaucoma	0.000486	0.00246	CcSEcCtD
Tolterodine—Palpitations—Dorzolamide—glaucoma	0.000485	0.00246	CcSEcCtD
Tolterodine—Vertigo—Brinzolamide—glaucoma	0.000485	0.00246	CcSEcCtD
Tolterodine—Dysuria—Betaxolol—glaucoma	0.000484	0.00245	CcSEcCtD
Tolterodine—Diarrhoea—Methazolamide—glaucoma	0.000483	0.00245	CcSEcCtD
Tolterodine—Palpitations—Travoprost—glaucoma	0.000483	0.00245	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Betaxolol—glaucoma	0.000481	0.00244	CcSEcCtD
Tolterodine—Headache—Diclofenamide—glaucoma	0.00048	0.00243	CcSEcCtD
Tolterodine—Dry mouth—Brimonidine—glaucoma	0.000478	0.00243	CcSEcCtD
Tolterodine—Palpitations—Brinzolamide—glaucoma	0.000477	0.00242	CcSEcCtD
Tolterodine—Hallucination—Clonidine—glaucoma	0.000473	0.0024	CcSEcCtD
Tolterodine—Fatigue—Apraclonidine—glaucoma	0.000471	0.00239	CcSEcCtD
Tolterodine—Weight increased—Betaxolol—glaucoma	0.000471	0.00239	CcSEcCtD
Tolterodine—Somnolence—Bimatoprost—glaucoma	0.000471	0.00239	CcSEcCtD
Tolterodine—Oedema—Brimonidine—glaucoma	0.000469	0.00238	CcSEcCtD
Tolterodine—Headache—Carbachol—glaucoma	0.000469	0.00238	CcSEcCtD
Tolterodine—Chest pain—Dorzolamide—glaucoma	0.000467	0.00237	CcSEcCtD
Tolterodine—Arthralgia—Dorzolamide—glaucoma	0.000467	0.00237	CcSEcCtD
Tolterodine—Pain—Apraclonidine—glaucoma	0.000467	0.00237	CcSEcCtD
Tolterodine—Constipation—Apraclonidine—glaucoma	0.000467	0.00237	CcSEcCtD
Tolterodine—Dyspepsia—Bimatoprost—glaucoma	0.000466	0.00236	CcSEcCtD
Tolterodine—Infection—Brimonidine—glaucoma	0.000466	0.00236	CcSEcCtD
Tolterodine—Anxiety—Dorzolamide—glaucoma	0.000466	0.00236	CcSEcCtD
Tolterodine—Arthralgia—Travoprost—glaucoma	0.000465	0.00236	CcSEcCtD
Tolterodine—Chest pain—Travoprost—glaucoma	0.000465	0.00236	CcSEcCtD
Tolterodine—Anxiety—Travoprost—glaucoma	0.000464	0.00235	CcSEcCtD
Tolterodine—Headache—Levobunolol—glaucoma	0.000462	0.00234	CcSEcCtD
Tolterodine—Arthralgia—Brinzolamide—glaucoma	0.000459	0.00233	CcSEcCtD
Tolterodine—Chest pain—Brinzolamide—glaucoma	0.000459	0.00233	CcSEcCtD
Tolterodine—Palpitations—Pilocarpine—glaucoma	0.000458	0.00232	CcSEcCtD
Tolterodine—Tachycardia—Brimonidine—glaucoma	0.000458	0.00232	CcSEcCtD
Tolterodine—Dry mouth—Dorzolamide—glaucoma	0.000457	0.00232	CcSEcCtD
Tolterodine—Dry mouth—Travoprost—glaucoma	0.000455	0.00231	CcSEcCtD
Tolterodine—Pain—Bimatoprost—glaucoma	0.000453	0.0023	CcSEcCtD
Tolterodine—Dizziness—Latanoprost—glaucoma	0.000452	0.00229	CcSEcCtD
Tolterodine—Confusional state—Dorzolamide—glaucoma	0.000452	0.00229	CcSEcCtD
Tolterodine—Feeling abnormal—Apraclonidine—glaucoma	0.00045	0.00228	CcSEcCtD
Tolterodine—Dry mouth—Brinzolamide—glaucoma	0.000449	0.00228	CcSEcCtD
Tolterodine—Oedema—Dorzolamide—glaucoma	0.000448	0.00227	CcSEcCtD
Tolterodine—Anaphylactic shock—Dorzolamide—glaucoma	0.000448	0.00227	CcSEcCtD
Tolterodine—Gastrointestinal pain—Apraclonidine—glaucoma	0.000447	0.00226	CcSEcCtD
Tolterodine—Oedema—Travoprost—glaucoma	0.000446	0.00226	CcSEcCtD
Tolterodine—Infection—Travoprost—glaucoma	0.000443	0.00225	CcSEcCtD
Tolterodine—Headache—Methazolamide—glaucoma	0.000442	0.00224	CcSEcCtD
Tolterodine—Arthralgia—Pilocarpine—glaucoma	0.000441	0.00224	CcSEcCtD
Tolterodine—Chest pain—Pilocarpine—glaucoma	0.000441	0.00224	CcSEcCtD
Tolterodine—Anxiety—Pilocarpine—glaucoma	0.00044	0.00223	CcSEcCtD
Tolterodine—Infection—Brinzolamide—glaucoma	0.000437	0.00222	CcSEcCtD
Tolterodine—Tachycardia—Travoprost—glaucoma	0.000435	0.00221	CcSEcCtD
Tolterodine—Somnolence—Acetazolamide—glaucoma	0.000434	0.0022	CcSEcCtD
Tolterodine—Sinusitis—Betaxolol—glaucoma	0.000433	0.00219	CcSEcCtD
Tolterodine—Abdominal pain—Apraclonidine—glaucoma	0.000432	0.00219	CcSEcCtD
Tolterodine—Dyspepsia—Acetazolamide—glaucoma	0.00043	0.00218	CcSEcCtD
Tolterodine—Tachycardia—Brinzolamide—glaucoma	0.00043	0.00218	CcSEcCtD
Tolterodine—Headache—Latanoprost—glaucoma	0.000428	0.00217	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000427	0.00217	CcSEcCtD
Tolterodine—Confusional state—Pilocarpine—glaucoma	0.000427	0.00216	CcSEcCtD
Tolterodine—Oedema—Pilocarpine—glaucoma	0.000423	0.00215	CcSEcCtD
Tolterodine—Fatigue—Acetazolamide—glaucoma	0.000421	0.00214	CcSEcCtD
Tolterodine—Infection—Pilocarpine—glaucoma	0.00042	0.00213	CcSEcCtD
Tolterodine—Somnolence—Brimonidine—glaucoma	0.000417	0.00211	CcSEcCtD
Tolterodine—Tachycardia—Pilocarpine—glaucoma	0.000413	0.00209	CcSEcCtD
Tolterodine—Dyspepsia—Brimonidine—glaucoma	0.000413	0.00209	CcSEcCtD
Tolterodine—Hallucination—Betaxolol—glaucoma	0.000412	0.00209	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000408	0.00207	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Travoprost—glaucoma	0.000406	0.00206	CcSEcCtD
Tolterodine—Fatigue—Brimonidine—glaucoma	0.000404	0.00205	CcSEcCtD
Tolterodine—Feeling abnormal—Acetazolamide—glaucoma	0.000403	0.00204	CcSEcCtD
Tolterodine—Hypersensitivity—Apraclonidine—glaucoma	0.000402	0.00204	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000401	0.00203	CcSEcCtD
Tolterodine—Pain—Brimonidine—glaucoma	0.000401	0.00203	CcSEcCtD
Tolterodine—Visual impairment—Betaxolol—glaucoma	0.000399	0.00202	CcSEcCtD
Tolterodine—Somnolence—Dorzolamide—glaucoma	0.000398	0.00202	CcSEcCtD
Tolterodine—Dysuria—Timolol—glaucoma	0.000395	0.002	CcSEcCtD
Tolterodine—Dyspepsia—Dorzolamide—glaucoma	0.000394	0.002	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Timolol—glaucoma	0.000393	0.00199	CcSEcCtD
Tolterodine—Dyspepsia—Travoprost—glaucoma	0.000393	0.00199	CcSEcCtD
Tolterodine—Asthenia—Apraclonidine—glaucoma	0.000392	0.00199	CcSEcCtD
Tolterodine—Somnolence—Brinzolamide—glaucoma	0.000391	0.00198	CcSEcCtD
Tolterodine—Dyspepsia—Brinzolamide—glaucoma	0.000388	0.00196	CcSEcCtD
Tolterodine—Fatigue—Dorzolamide—glaucoma	0.000386	0.00196	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000386	0.00195	CcSEcCtD
Tolterodine—Fatigue—Travoprost—glaucoma	0.000384	0.00195	CcSEcCtD
Tolterodine—Flushing—Betaxolol—glaucoma	0.000384	0.00195	CcSEcCtD
Tolterodine—Pain—Dorzolamide—glaucoma	0.000383	0.00194	CcSEcCtD
Tolterodine—Constipation—Travoprost—glaucoma	0.000381	0.00193	CcSEcCtD
Tolterodine—Pain—Travoprost—glaucoma	0.000381	0.00193	CcSEcCtD
Tolterodine—Asthenia—Bimatoprost—glaucoma	0.00038	0.00193	CcSEcCtD
Tolterodine—Fatigue—Brinzolamide—glaucoma	0.00038	0.00192	CcSEcCtD
Tolterodine—Angioedema—Clonidine—glaucoma	0.000378	0.00192	CcSEcCtD
Tolterodine—Pain—Brinzolamide—glaucoma	0.000377	0.00191	CcSEcCtD
Tolterodine—Somnolence—Pilocarpine—glaucoma	0.000376	0.00191	CcSEcCtD
Tolterodine—Diarrhoea—Apraclonidine—glaucoma	0.000374	0.00189	CcSEcCtD
Tolterodine—Dyspepsia—Pilocarpine—glaucoma	0.000373	0.00189	CcSEcCtD
Tolterodine—Feeling abnormal—Dorzolamide—glaucoma	0.000369	0.00187	CcSEcCtD
Tolterodine—Feeling abnormal—Travoprost—glaucoma	0.000367	0.00186	CcSEcCtD
Tolterodine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000366	0.00186	CcSEcCtD
Tolterodine—Palpitations—Clonidine—glaucoma	0.000366	0.00186	CcSEcCtD
Tolterodine—Gastrointestinal pain—Travoprost—glaucoma	0.000365	0.00185	CcSEcCtD
Tolterodine—Feeling abnormal—Brinzolamide—glaucoma	0.000363	0.00184	CcSEcCtD
Tolterodine—Pain—Pilocarpine—glaucoma	0.000362	0.00183	CcSEcCtD
Tolterodine—Constipation—Pilocarpine—glaucoma	0.000362	0.00183	CcSEcCtD
Tolterodine—Dizziness—Apraclonidine—glaucoma	0.000361	0.00183	CcSEcCtD
Tolterodine—Abdominal pain—Dorzolamide—glaucoma	0.000354	0.00179	CcSEcCtD
Tolterodine—Sinusitis—Timolol—glaucoma	0.000354	0.00179	CcSEcCtD
Tolterodine—Arthralgia—Clonidine—glaucoma	0.000353	0.00179	CcSEcCtD
Tolterodine—Chest pain—Clonidine—glaucoma	0.000353	0.00179	CcSEcCtD
Tolterodine—Abdominal pain—Travoprost—glaucoma	0.000353	0.00179	CcSEcCtD
Tolterodine—Anxiety—Clonidine—glaucoma	0.000351	0.00178	CcSEcCtD
Tolterodine—Asthenia—Acetazolamide—glaucoma	0.000351	0.00178	CcSEcCtD
Tolterodine—Dizziness—Bimatoprost—glaucoma	0.00035	0.00178	CcSEcCtD
Tolterodine—Feeling abnormal—Pilocarpine—glaucoma	0.000349	0.00177	CcSEcCtD
Tolterodine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000346	0.00175	CcSEcCtD
Tolterodine—Hypersensitivity—Brimonidine—glaucoma	0.000345	0.00175	CcSEcCtD
Tolterodine—Dry mouth—Clonidine—glaucoma	0.000345	0.00175	CcSEcCtD
Tolterodine—Headache—Apraclonidine—glaucoma	0.000342	0.00173	CcSEcCtD
Tolterodine—Confusional state—Clonidine—glaucoma	0.000341	0.00173	CcSEcCtD
Tolterodine—Oedema—Clonidine—glaucoma	0.000338	0.00171	CcSEcCtD
Tolterodine—Hallucination—Timolol—glaucoma	0.000337	0.00171	CcSEcCtD
Tolterodine—Asthenia—Brimonidine—glaucoma	0.000336	0.00171	CcSEcCtD
Tolterodine—Infection—Clonidine—glaucoma	0.000336	0.0017	CcSEcCtD
Tolterodine—Abdominal pain—Pilocarpine—glaucoma	0.000335	0.0017	CcSEcCtD
Tolterodine—Diarrhoea—Acetazolamide—glaucoma	0.000334	0.00169	CcSEcCtD
Tolterodine—Oedema peripheral—Timolol—glaucoma	0.000333	0.00169	CcSEcCtD
Tolterodine—Headache—Bimatoprost—glaucoma	0.000332	0.00168	CcSEcCtD
Tolterodine—Hypersensitivity—Dorzolamide—glaucoma	0.00033	0.00167	CcSEcCtD
Tolterodine—Tachycardia—Clonidine—glaucoma	0.00033	0.00167	CcSEcCtD
Tolterodine—Hypersensitivity—Travoprost—glaucoma	0.000329	0.00167	CcSEcCtD
Tolterodine—Visual impairment—Timolol—glaucoma	0.000326	0.00165	CcSEcCtD
Tolterodine—Hypersensitivity—Brinzolamide—glaucoma	0.000324	0.00164	CcSEcCtD
Tolterodine—Vertigo—Betaxolol—glaucoma	0.000324	0.00164	CcSEcCtD
Tolterodine—Dizziness—Acetazolamide—glaucoma	0.000323	0.00164	CcSEcCtD
Tolterodine—Asthenia—Dorzolamide—glaucoma	0.000321	0.00163	CcSEcCtD
Tolterodine—Asthenia—Travoprost—glaucoma	0.00032	0.00162	CcSEcCtD
Tolterodine—Palpitations—Betaxolol—glaucoma	0.000319	0.00161	CcSEcCtD
Tolterodine—Asthenia—Brinzolamide—glaucoma	0.000316	0.0016	CcSEcCtD
Tolterodine—Hypersensitivity—Pilocarpine—glaucoma	0.000312	0.00158	CcSEcCtD
Tolterodine—Dizziness—Brimonidine—glaucoma	0.00031	0.00157	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000308	0.00156	CcSEcCtD
Tolterodine—Arthralgia—Betaxolol—glaucoma	0.000307	0.00156	CcSEcCtD
Tolterodine—Chest pain—Betaxolol—glaucoma	0.000307	0.00156	CcSEcCtD
Tolterodine—Diarrhoea—Dorzolamide—glaucoma	0.000306	0.00155	CcSEcCtD
Tolterodine—Headache—Acetazolamide—glaucoma	0.000306	0.00155	CcSEcCtD
Tolterodine—Anxiety—Betaxolol—glaucoma	0.000306	0.00155	CcSEcCtD
Tolterodine—Diarrhoea—Travoprost—glaucoma	0.000305	0.00155	CcSEcCtD
Tolterodine—Asthenia—Pilocarpine—glaucoma	0.000304	0.00154	CcSEcCtD
Tolterodine—Diarrhoea—Brinzolamide—glaucoma	0.000301	0.00153	CcSEcCtD
Tolterodine—Somnolence—Clonidine—glaucoma	0.0003	0.00152	CcSEcCtD
Tolterodine—Dry mouth—Betaxolol—glaucoma	0.0003	0.00152	CcSEcCtD
Tolterodine—Confusional state—Betaxolol—glaucoma	0.000297	0.0015	CcSEcCtD
Tolterodine—Dizziness—Dorzolamide—glaucoma	0.000296	0.0015	CcSEcCtD
Tolterodine—Dizziness—Travoprost—glaucoma	0.000295	0.00149	CcSEcCtD
Tolterodine—Oedema—Betaxolol—glaucoma	0.000294	0.00149	CcSEcCtD
Tolterodine—Headache—Brimonidine—glaucoma	0.000294	0.00149	CcSEcCtD
Tolterodine—Infection—Betaxolol—glaucoma	0.000292	0.00148	CcSEcCtD
Tolterodine—Fatigue—Clonidine—glaucoma	0.000291	0.00148	CcSEcCtD
Tolterodine—Dizziness—Brinzolamide—glaucoma	0.000291	0.00148	CcSEcCtD
Tolterodine—Diarrhoea—Pilocarpine—glaucoma	0.00029	0.00147	CcSEcCtD
Tolterodine—Constipation—Clonidine—glaucoma	0.000289	0.00147	CcSEcCtD
Tolterodine—Pain—Clonidine—glaucoma	0.000289	0.00147	CcSEcCtD
Tolterodine—Tachycardia—Betaxolol—glaucoma	0.000287	0.00146	CcSEcCtD
Tolterodine—Headache—Dorzolamide—glaucoma	0.000281	0.00142	CcSEcCtD
Tolterodine—Dizziness—Pilocarpine—glaucoma	0.00028	0.00142	CcSEcCtD
Tolterodine—Headache—Travoprost—glaucoma	0.000279	0.00142	CcSEcCtD
Tolterodine—Feeling abnormal—Clonidine—glaucoma	0.000278	0.00141	CcSEcCtD
Tolterodine—Gastrointestinal pain—Clonidine—glaucoma	0.000276	0.0014	CcSEcCtD
Tolterodine—Headache—Brinzolamide—glaucoma	0.000276	0.0014	CcSEcCtD
Tolterodine—Angioedema—Timolol—glaucoma	0.000269	0.00136	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000268	0.00136	CcSEcCtD
Tolterodine—Abdominal pain—Clonidine—glaucoma	0.000267	0.00135	CcSEcCtD
Tolterodine—Headache—Pilocarpine—glaucoma	0.000265	0.00134	CcSEcCtD
Tolterodine—Vertigo—Timolol—glaucoma	0.000265	0.00134	CcSEcCtD
Tolterodine—Palpitations—Timolol—glaucoma	0.00026	0.00132	CcSEcCtD
Tolterodine—Dyspepsia—Betaxolol—glaucoma	0.000259	0.00131	CcSEcCtD
Tolterodine—Fatigue—Betaxolol—glaucoma	0.000254	0.00129	CcSEcCtD
Tolterodine—Constipation—Betaxolol—glaucoma	0.000252	0.00128	CcSEcCtD
Tolterodine—Pain—Betaxolol—glaucoma	0.000252	0.00128	CcSEcCtD
Tolterodine—Chest pain—Timolol—glaucoma	0.000251	0.00127	CcSEcCtD
Tolterodine—Arthralgia—Timolol—glaucoma	0.000251	0.00127	CcSEcCtD
Tolterodine—Anxiety—Timolol—glaucoma	0.00025	0.00127	CcSEcCtD
Tolterodine—Hypersensitivity—Clonidine—glaucoma	0.000249	0.00126	CcSEcCtD
Tolterodine—Dry mouth—Timolol—glaucoma	0.000245	0.00124	CcSEcCtD
Tolterodine—Asthenia—Clonidine—glaucoma	0.000242	0.00123	CcSEcCtD
Tolterodine—Feeling abnormal—Betaxolol—glaucoma	0.000242	0.00123	CcSEcCtD
Tolterodine—Confusional state—Timolol—glaucoma	0.000242	0.00123	CcSEcCtD
Tolterodine—Anaphylactic shock—Timolol—glaucoma	0.00024	0.00122	CcSEcCtD
Tolterodine—Oedema—Timolol—glaucoma	0.00024	0.00122	CcSEcCtD
Tolterodine—Infection—Timolol—glaucoma	0.000239	0.00121	CcSEcCtD
Tolterodine—Diarrhoea—Clonidine—glaucoma	0.000231	0.00117	CcSEcCtD
Tolterodine—Dizziness—Clonidine—glaucoma	0.000223	0.00113	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Timolol—glaucoma	0.000219	0.00111	CcSEcCtD
Tolterodine—Hypersensitivity—Betaxolol—glaucoma	0.000217	0.0011	CcSEcCtD
Tolterodine—Somnolence—Timolol—glaucoma	0.000214	0.00108	CcSEcCtD
Tolterodine—Headache—Clonidine—glaucoma	0.000212	0.00107	CcSEcCtD
Tolterodine—Dyspepsia—Timolol—glaucoma	0.000212	0.00107	CcSEcCtD
Tolterodine—Asthenia—Betaxolol—glaucoma	0.000211	0.00107	CcSEcCtD
Tolterodine—Fatigue—Timolol—glaucoma	0.000207	0.00105	CcSEcCtD
Tolterodine—Pain—Timolol—glaucoma	0.000206	0.00104	CcSEcCtD
Tolterodine—Diarrhoea—Betaxolol—glaucoma	0.000201	0.00102	CcSEcCtD
Tolterodine—Feeling abnormal—Timolol—glaucoma	0.000198	0.001	CcSEcCtD
Tolterodine—Gastrointestinal pain—Timolol—glaucoma	0.000197	0.000996	CcSEcCtD
Tolterodine—Dizziness—Betaxolol—glaucoma	0.000195	0.000986	CcSEcCtD
Tolterodine—Abdominal pain—Timolol—glaucoma	0.00019	0.000963	CcSEcCtD
Tolterodine—Headache—Betaxolol—glaucoma	0.000184	0.000934	CcSEcCtD
Tolterodine—Hypersensitivity—Timolol—glaucoma	0.000177	0.000898	CcSEcCtD
Tolterodine—Asthenia—Timolol—glaucoma	0.000172	0.000874	CcSEcCtD
Tolterodine—Diarrhoea—Timolol—glaucoma	0.000164	0.000834	CcSEcCtD
Tolterodine—Dizziness—Timolol—glaucoma	0.000159	0.000806	CcSEcCtD
Tolterodine—Headache—Timolol—glaucoma	0.000151	0.000763	CcSEcCtD
Tolterodine—CHRM5—Signaling Pathways—OPN4—glaucoma	3.04e-05	0.00151	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—C3—glaucoma	3.01e-05	0.0015	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—EDN1—glaucoma	3e-05	0.00149	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HEYL—glaucoma	2.95e-05	0.00147	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CA5A—glaucoma	2.91e-05	0.00144	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NARFL—glaucoma	2.91e-05	0.00144	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NARFL—glaucoma	2.88e-05	0.00143	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CA5A—glaucoma	2.88e-05	0.00143	CbGpPWpGaD
Tolterodine—CYP2C19—Biological oxidations—GSTM1—glaucoma	2.87e-05	0.00143	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PTGFR—glaucoma	2.86e-05	0.00142	CbGpPWpGaD
Tolterodine—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.83e-05	0.00141	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HEYL—glaucoma	2.83e-05	0.0014	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.78e-05	0.00138	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.77e-05	0.00137	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.74e-05	0.00136	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—C3—glaucoma	2.74e-05	0.00136	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PTGFR—glaucoma	2.74e-05	0.00136	CbGpPWpGaD
Tolterodine—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.71e-05	0.00135	CbGpPWpGaD
Tolterodine—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.64e-05	0.00131	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—C3—glaucoma	2.62e-05	0.0013	CbGpPWpGaD
Tolterodine—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.62e-05	0.0013	CbGpPWpGaD
Tolterodine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.61e-05	0.00129	CbGpPWpGaD
Tolterodine—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.58e-05	0.00128	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—SMO—glaucoma	2.44e-05	0.00121	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.43e-05	0.0012	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.42e-05	0.0012	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.4e-05	0.00119	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CA1—glaucoma	2.37e-05	0.00118	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—SMO—glaucoma	2.34e-05	0.00116	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CTSA—glaucoma	2.3e-05	0.00114	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—RPTOR—glaucoma	2.24e-05	0.00111	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CA2—glaucoma	2.17e-05	0.00108	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NCK2—glaucoma	2.17e-05	0.00108	CbGpPWpGaD
Tolterodine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.16e-05	0.00107	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—RPTOR—glaucoma	2.14e-05	0.00106	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—OPN4—glaucoma	2.14e-05	0.00106	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—OPN4—glaucoma	2.14e-05	0.00106	CbGpPWpGaD
Tolterodine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.13e-05	0.00106	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—EDN1—glaucoma	2.12e-05	0.00105	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—OPN4—glaucoma	2.11e-05	0.00105	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—EDN1—glaucoma	2.11e-05	0.00105	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.1e-05	0.00104	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—EDN1—glaucoma	2.09e-05	0.00104	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NCK2—glaucoma	2.08e-05	0.00103	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HEYL—glaucoma	1.99e-05	0.000989	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HEYL—glaucoma	1.99e-05	0.000986	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HEYL—glaucoma	1.97e-05	0.000976	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PTGFR—glaucoma	1.93e-05	0.000958	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PTGFR—glaucoma	1.92e-05	0.000955	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PTGFR—glaucoma	1.9e-05	0.000946	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CA5A—glaucoma	1.9e-05	0.000944	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NARFL—glaucoma	1.9e-05	0.000944	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—C3—glaucoma	1.85e-05	0.000918	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HDAC9—glaucoma	1.84e-05	0.000915	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—C3—glaucoma	1.84e-05	0.000915	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—C3—glaucoma	1.82e-05	0.000906	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	1.8e-05	0.000894	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—EDN1—glaucoma	1.77e-05	0.00088	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HDAC9—glaucoma	1.77e-05	0.000877	CbGpPWpGaD
Tolterodine—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.73e-05	0.000858	CbGpPWpGaD
Tolterodine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.7e-05	0.000846	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—EDN1—glaucoma	1.7e-05	0.000843	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—SMO—glaucoma	1.65e-05	0.000818	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—SMO—glaucoma	1.64e-05	0.000815	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—SMO—glaucoma	1.63e-05	0.000807	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—EDN1—glaucoma	1.61e-05	0.000799	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—C3—glaucoma	1.55e-05	0.000769	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CA1—glaucoma	1.54e-05	0.000766	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—EDN1—glaucoma	1.54e-05	0.000766	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—TXN—glaucoma	1.53e-05	0.00076	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RPTOR—glaucoma	1.51e-05	0.00075	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RPTOR—glaucoma	1.5e-05	0.000747	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CTSA—glaucoma	1.49e-05	0.000742	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RPTOR—glaucoma	1.49e-05	0.00074	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—C3—glaucoma	1.48e-05	0.000736	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NCK2—glaucoma	1.46e-05	0.000726	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NCK2—glaucoma	1.46e-05	0.000724	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NCK2—glaucoma	1.44e-05	0.000717	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SMO—glaucoma	1.44e-05	0.000716	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CA1—glaucoma	1.42e-05	0.000705	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CA2—glaucoma	1.41e-05	0.000701	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CA1—glaucoma	1.41e-05	0.000699	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—C3—glaucoma	1.41e-05	0.000698	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SMO—glaucoma	1.38e-05	0.000686	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.38e-05	0.000685	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.38e-05	0.000685	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CTSA—glaucoma	1.37e-05	0.000683	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CTSA—glaucoma	1.36e-05	0.000677	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—C3—glaucoma	1.35e-05	0.000669	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NTRK2—glaucoma	1.32e-05	0.000655	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—TP53—glaucoma	1.31e-05	0.000652	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CA2—glaucoma	1.3e-05	0.000645	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CA2—glaucoma	1.29e-05	0.000639	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NTRK2—glaucoma	1.26e-05	0.000627	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.26e-05	0.000625	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.26e-05	0.000625	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HDAC9—glaucoma	1.24e-05	0.000617	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HDAC9—glaucoma	1.24e-05	0.000615	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HDAC9—glaucoma	1.23e-05	0.000609	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—EDN1—glaucoma	1.2e-05	0.000594	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—EDN1—glaucoma	1.19e-05	0.000592	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GSTT1—glaucoma	1.19e-05	0.000589	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—EDN1—glaucoma	1.18e-05	0.000586	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NGFR—glaucoma	1.13e-05	0.000562	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—EDN1—glaucoma	1.09e-05	0.000539	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NGFR—glaucoma	1.08e-05	0.000538	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—EDN1—glaucoma	1.08e-05	0.000537	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NTRK1—glaucoma	1.08e-05	0.000534	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—EDN1—glaucoma	1.07e-05	0.000532	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—C3—glaucoma	1.04e-05	0.000519	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—C3—glaucoma	1.04e-05	0.000517	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—C3—glaucoma	1.03e-05	0.000512	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NTRK1—glaucoma	1.03e-05	0.000511	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—TXN—glaucoma	9.95e-06	0.000494	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CDKN2B—glaucoma	9.91e-06	0.000492	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SMO—glaucoma	9.73e-06	0.000483	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SMO—glaucoma	9.7e-06	0.000481	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SMO—glaucoma	9.6e-06	0.000477	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—EDN1—glaucoma	9.51e-06	0.000472	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CDKN2B—glaucoma	9.49e-06	0.000471	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—C3—glaucoma	9.48e-06	0.000471	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—C3—glaucoma	9.45e-06	0.000469	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CYP1B1—glaucoma	9.45e-06	0.000469	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ABCA1—glaucoma	9.45e-06	0.000469	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—C3—glaucoma	9.36e-06	0.000465	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CA1—glaucoma	9.28e-06	0.000461	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—TXN—glaucoma	9.15e-06	0.000454	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—EDN1—glaucoma	9.11e-06	0.000452	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.08e-06	0.000451	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—TXN—glaucoma	9.07e-06	0.00045	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.99e-06	0.000447	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CTSA—glaucoma	8.99e-06	0.000446	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NTRK2—glaucoma	8.9e-06	0.000442	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NTRK2—glaucoma	8.87e-06	0.00044	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NTRK2—glaucoma	8.78e-06	0.000436	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NGF—glaucoma	8.74e-06	0.000434	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CA2—glaucoma	8.49e-06	0.000422	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NGF—glaucoma	8.37e-06	0.000416	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—C3—glaucoma	8.31e-06	0.000413	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.28e-06	0.000411	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.2e-06	0.000407	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—C3—glaucoma	7.96e-06	0.000395	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—APOE—glaucoma	7.73e-06	0.000384	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTT1—glaucoma	7.71e-06	0.000383	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CAV1—glaucoma	7.66e-06	0.000381	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NGFR—glaucoma	7.63e-06	0.000379	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NGFR—glaucoma	7.61e-06	0.000378	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GSTM1—glaucoma	7.56e-06	0.000375	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NGFR—glaucoma	7.53e-06	0.000374	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—APOE—glaucoma	7.41e-06	0.000368	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CAV1—glaucoma	7.34e-06	0.000364	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—FN1—glaucoma	7.29e-06	0.000362	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NTRK1—glaucoma	7.25e-06	0.00036	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NTRK1—glaucoma	7.23e-06	0.000359	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—BAD—glaucoma	7.21e-06	0.000358	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NTRK1—glaucoma	7.16e-06	0.000355	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTT1—glaucoma	7.09e-06	0.000352	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTT1—glaucoma	7.03e-06	0.000349	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—FN1—glaucoma	6.99e-06	0.000347	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—BAD—glaucoma	6.9e-06	0.000343	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CDKN2B—glaucoma	6.68e-06	0.000332	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MTHFR—glaucoma	6.68e-06	0.000332	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CDKN2B—glaucoma	6.66e-06	0.000331	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CDKN2B—glaucoma	6.6e-06	0.000328	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—EDN1—glaucoma	6.41e-06	0.000318	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—EDN1—glaucoma	6.39e-06	0.000317	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—EDN1—glaucoma	6.33e-06	0.000314	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.22e-06	0.000309	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—APOE—glaucoma	6.22e-06	0.000309	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CAV1—glaucoma	6.16e-06	0.000306	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP1B1—glaucoma	6.15e-06	0.000305	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ABCA1—glaucoma	6.15e-06	0.000305	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TXN—glaucoma	5.98e-06	0.000297	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NGF—glaucoma	5.89e-06	0.000293	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NGF—glaucoma	5.87e-06	0.000292	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NGF—glaucoma	5.82e-06	0.000289	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NOS3—glaucoma	5.79e-06	0.000288	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.67e-06	0.000282	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ABCA1—glaucoma	5.65e-06	0.000281	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP1B1—glaucoma	5.65e-06	0.000281	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ABCA1—glaucoma	5.6e-06	0.000278	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP1B1—glaucoma	5.6e-06	0.000278	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—C3—glaucoma	5.6e-06	0.000278	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—C3—glaucoma	5.58e-06	0.000277	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NOS3—glaucoma	5.55e-06	0.000276	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—C3—glaucoma	5.53e-06	0.000275	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APOE—glaucoma	5.22e-06	0.000259	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APOE—glaucoma	5.2e-06	0.000258	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CAV1—glaucoma	5.17e-06	0.000257	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CAV1—glaucoma	5.15e-06	0.000256	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APOE—glaucoma	5.15e-06	0.000256	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CAV1—glaucoma	5.1e-06	0.000253	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CDKN1B—glaucoma	5.02e-06	0.000249	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FN1—glaucoma	4.92e-06	0.000244	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTM1—glaucoma	4.91e-06	0.000244	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FN1—glaucoma	4.9e-06	0.000243	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—BAD—glaucoma	4.86e-06	0.000241	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FN1—glaucoma	4.86e-06	0.000241	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—BAD—glaucoma	4.84e-06	0.000241	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CDKN1B—glaucoma	4.81e-06	0.000239	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—BAD—glaucoma	4.8e-06	0.000238	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—NOS3—glaucoma	4.66e-06	0.000231	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MMP9—glaucoma	4.65e-06	0.000231	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTT1—glaucoma	4.64e-06	0.00023	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTM1—glaucoma	4.52e-06	0.000224	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTM1—glaucoma	4.48e-06	0.000222	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MMP9—glaucoma	4.45e-06	0.000221	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MTHFR—glaucoma	4.34e-06	0.000216	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTGS2—glaucoma	4.26e-06	0.000212	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—VEGFA—glaucoma	4.17e-06	0.000207	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOE—glaucoma	4.04e-06	0.000201	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CAV1—glaucoma	4e-06	0.000199	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—VEGFA—glaucoma	4e-06	0.000199	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MTHFR—glaucoma	3.99e-06	0.000198	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MTHFR—glaucoma	3.96e-06	0.000197	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NOS3—glaucoma	3.91e-06	0.000194	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NOS3—glaucoma	3.89e-06	0.000193	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NOS3—glaucoma	3.86e-06	0.000192	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOE—glaucoma	3.72e-06	0.000185	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ABCA1—glaucoma	3.7e-06	0.000183	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP1B1—glaucoma	3.7e-06	0.000183	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOE—glaucoma	3.69e-06	0.000183	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CAV1—glaucoma	3.68e-06	0.000183	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CAV1—glaucoma	3.65e-06	0.000181	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CDKN1B—glaucoma	3.38e-06	0.000168	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CDKN1B—glaucoma	3.37e-06	0.000168	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CDKN1B—glaucoma	3.34e-06	0.000166	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TP53—glaucoma	3.15e-06	0.000157	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MMP9—glaucoma	3.13e-06	0.000156	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MMP9—glaucoma	3.12e-06	0.000155	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MMP9—glaucoma	3.09e-06	0.000154	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NOS3—glaucoma	3.03e-06	0.00015	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TP53—glaucoma	3.02e-06	0.00015	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTM1—glaucoma	2.95e-06	0.000147	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—VEGFA—glaucoma	2.81e-06	0.00014	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—VEGFA—glaucoma	2.81e-06	0.000139	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NOS3—glaucoma	2.79e-06	0.000138	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—VEGFA—glaucoma	2.78e-06	0.000138	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGS2—glaucoma	2.77e-06	0.000138	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NOS3—glaucoma	2.76e-06	0.000137	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MTHFR—glaucoma	2.61e-06	0.00013	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGS2—glaucoma	2.55e-06	0.000126	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGS2—glaucoma	2.53e-06	0.000125	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOE—glaucoma	2.43e-06	0.000121	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CAV1—glaucoma	2.41e-06	0.00012	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TP53—glaucoma	2.13e-06	0.000106	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TP53—glaucoma	2.12e-06	0.000105	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TP53—glaucoma	2.1e-06	0.000104	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NOS3—glaucoma	1.82e-06	9.04e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS2—glaucoma	1.67e-06	8.27e-05	CbGpPWpGaD
